心脏骤停预后判断中体感诱发电位缺失的假阳性率估计
该研究通过PubMed检索纳入35项报告体感诱发电位的心脏骤停预后研究,共2133例受试者接受体感诱发电位检测,其中594例体感诱发电位缺失,14例功能结局良好。在35项研究中,14项可估计体感诱发电位缺失者的生命支持治疗撤除率(均值80%,中位数100%)。校正生命支持治疗撤除率为80%后,体感诱发电位缺失预测不良神经结局的假阳性率为7.7%(95%CI 4-13%)。结论认为,皮层体感诱发电位缺失不能绝对预测心脏骤停后昏迷患者的不良结局,其存活机会虽低但可能远高于普遍认识。
要点
- 体感诱发电位缺失预测心脏骤停后不良神经结局的假阳性率在校正生命支持治疗撤除率80%后为7.7%(95%CI 4-13%)。
- 594例体感诱发电位缺失者中14例功能结局良好,提示体感诱发电位缺失并非绝对预测不良结局。
- 35项研究中仅14项可估计体感诱发电位缺失者的生命支持治疗撤除率(均值80%,中位数100%)。
- 体感诱发电位缺失者的存活机会虽低,但可能远高于普遍认识。
适用人群与场景
- 心脏骤停后昏迷患者,接受体感诱发电位检测用于预后判断。
研究设计与关键结果
- 研究类型为通过PubMed检索的系统性文献分析,纳入35项报告体感诱发电位的心脏骤停预后研究。
- 共2133例受试者接受体感诱发电位检测,其中594例体感诱发电位缺失,14例功能结局良好。
- 35项研究中14项可估计体感诱发电位缺失者的生命支持治疗撤除率,均值80%,中位数100%。
- 校正生命支持治疗撤除率为80%后,体感诱发电位缺失预测不良神经结局的假阳性率为7.7%(95%CI 4-13%)。
证据类型、等级与局限
- 证据类型为基于PubMed检索的预后研究系统分析,使用Quality in Prognosis Studies工具评估偏倚。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,体感诱发电位缺失不能绝对预测心脏骤停后昏迷患者的不良结局,其存活机会虽低但可能远高于普遍认识。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Absence of somatosensory evoked potentials is considered a nearly perfect predictor of poor outcome after cardiac arrest. However, reports of good outcomes despite absent somatosensory evoked potentials and high rates of withdrawal of life-sustaining therapies have raised concerns that estimates of the prognostic value of absent somatosensory evoked potentials may be biased by self-fulfilling prophecies. We aimed to develop an unbiased estimate of the false positive rate of absent somatosensory evoked potentials as a predictor of poor outcome after cardiac arrest.
DATA SOURCES: PubMed.
STUDY SELECTION: We selected 35 studies in cardiac arrest prognostication that reported somatosensory evoked potentials.
DATA EXTRACTION: In each study, we identified rates of withdrawal of life-sustaining therapies and good outcomes despite absent somatosensory evoked potentials. We appraised studies for potential biases using the Quality in Prognosis Studies tool. Using these data, we developed a statistical model to estimate the false positive rate of absent somatosensory evoked potentials adjusted for withdrawal of life-sustaining therapies rate.
DATA SYNTHESIS: Two-thousand one-hundred thirty-three subjects underwent somatosensory evoked potential testing. Five-hundred ninety-four had absent somatosensory evoked potentials; of these, 14 had good functional outcomes. The rate of withdrawal of life-sustaining therapies for subjects with absent somatosensory evoked potential could be estimated in 14 of the 35 studies (mean 80%, median 100%). The false positive rate for absent somatosensory evoked potential in predicting poor neurologic outcome, adjusted for a withdrawal of life-sustaining therapies rate of 80%, is 7.7% (95% CI, 4-13%).
CONCLUSIONS: Absent cortical somatosensory evoked potentials do not infallibly predict poor outcome in patients with coma following cardiac arrest. The chances of survival in subjects with absent somatosensory evoked potentials, though low, may be substantially higher than generally believed.
参考来源
- Amorim E, Ghassemi MM, Lee JW, et al. Estimating the False Positive Rate of Absent Somatosensory Evoked Potentials in Cardiac Arrest Prognostication. Crit Care Med. 2018. PMID: 30247243. doi:10.1097/CCM.0000000000003436
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。